NRC HEALTH

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $20.5m $22.9m $30.0m $32.4m $37.3m $37.5m $31.8m $31.0m $24.8m $11.6m
Net Income (Loss) Available to Common Stockholders, Basic $20.5m $22.9m $30.0m $32.4m $37.3m $37.5m $31.8m $31.0m $24.8m $11.3m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $30.0m $32.4m $37.3m $37.5m $31.8m $31.0m $24.8m $11.6m
Depreciation and amortization $4.2m $4.6m $5.5m $5.5m $5.9m $6.0m $7.6m
Amortization of Debt Issuance Costs $39k $28k $102k
Amortization of Intangible Assets $654k $610k $662k $374k $318k $320k $180k $140k $264k $389k
Deferred Income Tax Expense (Benefit) $865k ($684k) $1.5m $1.1m ($134k) ($277k) ($1.7m) ($1.1m) ($664k) $2.5m
Share-based Payment Arrangement, Noncash Expense $1.9m $1.8m $1.5m $1.2m $680k $623k $1.2m $935k $284k $3.3m
Payment, Tax Withholding, Share-based Payment Arrangement $204k $1.7m $1.9m $1.1m $2.8m $721k $190k $0 $317k $407k
Goodwill, Impairment Loss $0 $0 $0 $0 $714k $0 $0 $0 $0 $0
Impairment of Intangible Assets (Excluding Goodwill) $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Operating Lease, Impairment Loss $324k $0 $0
Gain (Loss) on Disposition of Assets ($22k) ($26k) ($186k) $6k ($12k) ($7k) ($11k) $0 ($17k) ($61k)
Gain (Loss) on Extinguishment of Debt $0 $0 ($67k)
Income Tax Expense (Benefit) $10.8m $11.3m $4.7m $8.1m $4.2m $11.2m $11.0m $9.0m $7.9m $6.2m
Interest Expense Nonoperating $2.6m $4.8m
Other Nonoperating Income (Expense) $302k $50k $885k ($462k) $585k $4k ($118k) ($41k) ($34k) ($95k)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $1.0m $2.5m ($2.8m) ($311k) $2.3m ($343k) $733k ($2.1m) ($1.8m) $53k
Increase (Decrease) in Accounts Payable ($15k) $12k ($39k) $647k ($247k) $4k ($589k) $184k ($108k) $170k
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal $223k
Goodwill $57.9m $58.0m $57.8m $57.9m $57.3m $61.6m $61.6m $61.6m $66.2m $66.2m
Investment Income, Interest $47k $96k $62k $37k $18k $14k $168k $820k $125k $111k
Nonoperating Income (Expense) $159k $64k ($566k) ($2.5m) ($1.2m) ($1.6m) ($3.7m) ($83k) ($2.5m) ($4.7m)
Operating Expenses $78.2m $83.3m $84.4m
Proceeds from Stock Options Exercised $548k $0 $0 $0 $1.7m $446k $0 $584k $0 $132k
Revenue from Contract with Customer, Including Assessed Tax $119.7m
Net Cash Provided by (Used in) Operating Activities $26.8m $28.1m $39.8m $40.9m $40.6m $46.3m $36.3m $38.1m $34.6m $26.4m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $4.0m $4.6m $6.0m $4.7m $4.0m $5.5m $9.8m $15.8m $15.4m $10.7m
Payments to Acquire Investments $1.3m
Net Cash Provided by (Used in) Investing Activities ($3.8m) ($6.1m) ($6.0m) ($4.7m) ($3.7m) ($8.5m) ($9.8m) ($15.8m) ($20.3m) ($10.7m)
Cash flows from financing activities:
Payments for Repurchase of Common Stock $4.1m $27.6m $19.1m $30.9m $20.2m
Payments of Ordinary Dividends, Common Stock $28.6m $16.9m $16.9m $31.3m $10.5m $9.2m $21.0m $36.4m $11.5m $11.0m
Dividends Payable, Current $4.2m $4.2m $17.1m $5.2m $3.0m $3.0m $2.9m $2.8m $3.6m
Net Cash Provided by (Used in) Financing Activities ($32.5m) ($21.1m) ($54.5m) ($36.3m) ($15.5m) ($18.2m) ($55.6m) ($40.7m) ($16.8m) ($15.8m)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $285k $855k ($1.1m) $611k $21.2m $19.7m ($29.3m) ($18.4m) ($2.4m) ($94k)
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $1.3m $2.0m $1.7m $1.6m $1.3m $803k $2.4m $4.5m
Income Taxes Paid, Net $12.8m $2.6m $6.9m $5.2m $10.6m $12.2m $8.9m $8.2m